Extra Trump offers to decrease drug costs : Photographs

[ad_1] <img src="https://npr.brightspotcdn.com/dims3/default/strip/false/crop/8256x5504+0+0/resize/1100/quality/50/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F1c%2F74%2F632bdc6d4d198f7639342dcf73bd%2Fgettyimages-2252073612.jpg" data-template="https://npr.brightspotcdn.com/dims3/default/strip/false/crop/8256x5504+0+0/resize/{width}/quality/{quality}/format/{format}/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F1c%2F74%2F632bdc6d4d198f7639342dcf73bd%2Fgettyimages-2252073612.jpg" class="img" alt="President Trump unveiled deals with nine pharmaceutical companies on drug prices in a White House event Friday in Washington, DC, on December 19, 2025. (Photo by Brendan SMIALOWSKI / AFP via Getty Images)" fetchpriority="high"/> President Trump unveiled offers with 9 pharmaceutical corporations on drug costs in a White Home occasion Friday. BRENDAN SMIALOWSKI/AFP through Getty Photos cover caption

toggle caption

BRENDAN SMIALOWSKI/AFP through Getty Photos President Trump stated the administration has reached agreements with 9 extra drugmakers to convey their U.S. drug costs extra in step with what different rich nations pay.

Fourteen corporations in complete have now reached what the administration calls most-favored-nation pricing offers. The businesses that took half in Friday's announcement had been: Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi.

They agreed to cost the U.S. authorities no extra for brand new medication than the costs paid by different well-off nations. The agreements will permit state Medicaid applications to entry decrease costs from the 9 corporations. In a press release, the White Home stated the change will outcome "in billions of {dollars} in financial savings."

The drugmakers additionally agreed to take a position at the very least $150 billion in manufacturing operations within the U.S. The president is searching for to extend home manufacturing of prescribed drugs.

As well as, the businesses agreed to make a few of their hottest medication accessible at decrease costs to customers who pay out of pocket by means of a authorities web site referred to as TrumpRx.com. The TrumpRx web site is predicted to launch in early 2026, and would take customers to pharmaceutical corporations' direct-to-consumer web sites to satisfy orders.

For instance, Merck will cut back the value of Januvia, a medicine for Kind 2 diabetes, from $330 to $100 for sufferers buying instantly by means of TrumpRx, the White Home stated. Amgen will cut back the value of Repatha, a cholesterol-lowering drug, from $573 to $239 when bought by means of TrumpRx.

In change for these concessions, the businesses might be exempt from potential administration tariffs for 3 years.

The extent of financial savings for customers underneath the agreements is unclear. Medicaid and its beneficiaries already pay a number of the lowest costs for medication. And other people with medical insurance might spend much less on copays for his or her medicines than paying money for them by means of the drugmakers.

Individually, Trump stated through the press occasion that he want to get well being insurers to decrease their costs, too.

"I will name a gathering of the insurance coverage corporations," he stated. "I will see in the event that they [will] get their value down, to place it very bluntly."